The PennZone

  • Home
  • Business
  • Health
  • Construction
  • Real Estate
  • Technology
  • Non-profit
  • Travel
  • Home

SafeBreak® Vascular Cleared for Pediatrics
The PennZone/10232295

Trending...
  • Conexwest: Shipping Containers Are Powering the Next Generation of Bitcoin Mining Infrastructure
  • AktieGo Publishes Editorial Feature Examining Decentralized Power Infrastructure and Hydrogen Energy Deployment
  • Melzi Job Coach Launches on iOS and Android: A Privacy-First AI Career Engine Built for Execution
SafeBreak Vascular installed on a pediatric line SafeBreak Vascular installed on a pediatric line SafeBreak Vascular installed on a pediatric line Lineus Medical
FAYETTEVILLE, Ark. - PennZone -- Lineus Medical, a medical device company focused on reducing IV complications, announced that the company's flagship product, SafeBreak Vascular, has received clearance from the U.S. Food and Drug Administration (FDA) for use in pediatric patients. SafeBreak Vascular has been shown in adult clinical studies to reduce IV complications with its innovative breakaway technology1.

SafeBreak Vascular is the first breakaway device cleared by the FDA and proven to reduce IV complications in adults by 44%1. It fits between the IV tubing from the IV pump and the patient's IV access point at the arm. When there is a damaging force on the line, SafeBreak separates to protect the patient's IV. This innovative feature helps prevent accidental dislodgement of the catheter, as well as other IV complications caused by damaging forces on the IV line1. This is especially important for pediatric patients who may be more active, less inclined to follow instructions, and less aware of their surroundings.

More on The PennZone
  • Tony Grundler Introduces Artificial Intelligence V.S. Avatar-Ian's
  • Hollywood's Elite Gather at the Annual WOW Creations Oscars Gifting Suite at the Universal Hilton
  • Where Were the Women? Reframing the Greek Revolution Through Contemporary Art
  • IWS Press Publishes "Smart Money Shortcuts to Becoming Rich" by Tyler G. Hicks
  • JGCMGS Details Architecture to Safeguard Assets From Unauthorized Phishing Scams

"We are incredibly proud to receive clearance from the FDA for the use of SafeBreak Vascular with pediatric patients," said Vance Clement, CEO of Lineus Medical. "SafeBreak provides a simple, effective solution for preventing IV complications, which reduces IV restarts and additional needlesticks for patients.  Now, it doesn't matter if the patient is 1 or 100 years old, SafeBreak is cleared for use on all peripheral IVs.  Our goal is to have a SafeBreak on every IV line, everywhere in the world, and this additional clearance lets us help one of the most vulnerable populations that needs it the most, our kids."

ABOUT LINEUS MEDICAL

Lineus Medical is the developer of a unique, patented, break-away technology that is designed to work with all types of medical tubing. Complications with feeding tubes, IV lines, urinary catheters and any other type of medical tubing may be reduced as breakaway devices separate to protect the patient. More information about Lineus Medical can be found on the company website:  www.lineusmed.com or you can follow the company on Twitter or LinkedIn.

1 Dipper Study Data on File

MKG-0194 REV 00

Contact
Vance Clement
***@lineusmed.com


Source: Lineus Medical

Show All News | Report Violation

0 Comments
1000 characters max.

Latest on The PennZone
  • WCC Kitchens and Cabinets Featured on Selling Houses Australia
  • Cat Hunt Simulator : Burrow & Pounce Lands on the App Store
  • Shincheonji Marks 42nd Anniversary: From a Basement to a Denomination Growing by Tens of Thousands Annually
  • Imagen Golf Selected as Exclusive Golf Instruction Partner at The Birds Nest in New Hope, PA
  • Brain Drain Unlimited Foundation Achieves Candid Platinum Seal of Transparency
  • Jackets for Jobs Hosts Smart & Sexy® Day Detroit for Women's History Month
  • Tint Academy Training in Dallas Texas: Learn Window Tint & PPF Installation
  • $IBG accelerates toward transformative merger with BlockFuel as $6 million raise fuels dual-industry growth strategy: N A S D A Q: IBG
  • High-Growth Power Infrastructure Play Targets AI Boom: 1606 Corp. Executes Aggressive Texas Expansion Strategy: 1606 Corp. (Stock Symbol: CBDW) $CBDW
  • Accelerating the Transformation into a U.S. Nuclear Fuel Cycle Leader: Frontier Nuclear and Minerals Inc. (N A S D A Q: FNUC)
  • Ozz Metals Ltd Secures 1-Tonne Gold Offtake Agreement
  • Cultural Heritage Gallery Presents: Two Free Irish History Presentations Open to the Public
  • Jet Set: The Ultimate Coachella Afterparty
  • Heritage at Manalapan Introduces New Single-Family Home Community in One of Monmouth County's Most Desirable Locations
  • Compliant Workspace announces partnership with Blackpoint Cyber
  • Michigan Homeowners Urged to Act on Rising Basement Waterproofing Needs Amid Severe Flood
  • Event Solutions Enters New Era: Announces New Leadership
  • Carlsbad Hotel Named Best of La Quinta Award Winner
  • Vietnam Veterans Day Storytelling Event
  • Scoop Social Co. Launches a New Era of Mobile Hospitality — One Truck, Two Experiences

Popular on PennZone

  • Ice Melts. Infrastructure Fails. What Happens to Clean Water?
  • The Legal AI Showdown: Westlaw, Lexis, ChatGPT… or EvenSteven?
  • When Representation No Longer Reflects the District — Why I'm Voting for Pete Verbica
  • Diversified Roofing Solutions Strengthens Industry Leadership With Expanded Roofing Services Across South Florida
  • Kilmaine Saints to Anchor St. Patrick's Day Weekend with Live Album Recording at XL Live
  • Revolutionary Data Solution Transforms Health Insurance Underwriting Accuracy
  • François Arnaud, star of Heated Rivalry, is the real-life inspiration behind Christopher Stoddard's novel At Night Only
  • Art of Whiskey Hosts 3rd Annual San Francisco Tasting Experience During Super Bowl Week
  • Kobie Wins for AI Innovations in the 2026 Stevie® Awards for Sales & Customer Service
  • Postmortem Pathology Expands Independent Autopsy Services Across Colorado

Similar on PennZone

  • Inkdnylon Custom Apparel Launches Cost-Saving System for Promotional Products and Custom Apparel in Chicago
  • ENTOUCH Named Finalist for 2026 North American Inspiring Workplaces Awards
  • U.S. Government Contracts in Excess of 38 Million Secured Through Partner, Establishing Multi-Year Defense Revenue Platform Through 2032: $BLIS
  • Why Your Berberine Failed: RevGenetics Unveils the Absorption Gap Solution
  • High-Growth Power Infrastructure Play Targets AI Boom: 1606 Corp. Executes Aggressive Texas Expansion Strategy: 1606 Corp. (Stock Symbol: CBDW) $CBDW
  • Accelerating the Transformation into a U.S. Nuclear Fuel Cycle Leader: Frontier Nuclear and Minerals Inc. (N A S D A Q: FNUC)
  • Compliant Workspace announces partnership with Blackpoint Cyber
  • Innovative Environmental Technologies Unveils New Website Featuring Free AI Tools for the Environmental Industry
  • CCHR Warns: Psychiatric Diagnoses Without Biological Proof Now Used to Justify Euthanasia
  • JL Tox Consulting Responds to New ISO 10993-1:2025 Biocompatibility Standard Release
Copyright © The PennZone | Theme: OMag by LilyTurf Themes
  • Contribute
  • Privacy Policy
  • Terms of Service
  • Contact Us